Literature DB >> 25512362

The Association of Cytokine Levels With Cognitive Function in Children With Sickle Cell Disease and Normal MRI Studies of the Brain.

Charissa Andreotti1, Allison A King2, Elizabeth Macy3, Bruce E Compas4, Michael R DeBaun5.   

Abstract

Children with sickle cell disease, including those without evidence for cerebral infarcts, are at increased risk for cognitive deficits that can contribute to difficulties in academic and social functioning. Chronic inflammatory processes are endemic to sickle cell disease and are apparent in common comorbidities including asthma. Cytokines mediating inflammatory processes can influence cognition. The authors examined the relationship between plasma levels of cytokines commonly associated with asthma and cognitive functioning using standardized neuropsychological measures in 25 children with sickle cell disease with normal magnetic resonance imaging studies of the brain. Children with sickle cell disease performed significantly below the normative mean on tests of cognitive function. Pearson correlations indicated significant negative relations between cytokines (IL-4, IL-5, IL-8, and IL-13) and standardized tests of executive function (r = -.54 to -.74). Preliminary evidence suggests an association between cytokine levels and executive function in children with sickle cell disease, indicating a potential role for inflammatory processes in cognitive outcomes in these children.
© The Author(s) 2014.

Entities:  

Keywords:  asthma; cytokines; executive function; inflammation; sickle cell disease

Mesh:

Substances:

Year:  2014        PMID: 25512362      PMCID: PMC4466214          DOI: 10.1177/0883073814563140

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being.

Authors:  Ilia J Elenkov
Journal:  Neurochem Int       Date:  2007-07-10       Impact factor: 3.921

Review 3.  Sickle cell disease as a neurodevelopmental disorder.

Authors:  Jeffrey Schatz; Catherine B McClellan
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

4.  Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease.

Authors:  F Casamenti; C Prosperi; C Scali; L Giovannelli; M A Colivicchi; M S Faussone-Pellegrini; G Pepeu
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 5.  Sickle cell and the brain.

Authors:  R J Adams; K Ohene-Frempong; W Wang
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

Review 6.  Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.

Authors:  A Ashley-Koch; Q Yang; R S Olney
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

7.  Lesion burden and cognitive morbidity in children with sickle cell disease.

Authors:  Jeffrey Schatz; Desiree A White; Asif Moinuddin; Melissa Armstrong; Michael R DeBaun
Journal:  J Child Neurol       Date:  2002-12       Impact factor: 1.987

Review 8.  Evidence for a cytokine model of cognitive function.

Authors:  J McAfoose; B T Baune
Journal:  Neurosci Biobehav Rev       Date:  2008-10-18       Impact factor: 8.989

9.  Emotional, social, and behavioral functioning of children with sickle cell disease and comparison peers.

Authors:  Angie M Trzepacz; Kathryn Vannatta; Cynthia A Gerhardt; Christina Ramey; Robert B Noll
Journal:  J Pediatr Hematol Oncol       Date:  2004-10       Impact factor: 1.289

10.  Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells.

Authors:  Y H Yang; H J Lai; C M Huang; L C Wang; Y T Lin; B L Chiang
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

View more
  10 in total

1.  Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.

Authors:  Li Wang; Luis E F Almeida; Celia M de Souza Batista; Alfia Khaibullina; Nuo Xu; Sarah Albani; Kira A Guth; Ji Sung Seo; Martha Quezado; Zenaide M N Quezado
Journal:  Neurobiol Dis       Date:  2015-10-14       Impact factor: 5.996

Review 2.  Neurocognitive deficits in children with chronic health conditions.

Authors:  Bruce E Compas; Sarah S Jaser; Kristen Reeslund; Niral Patel; Janet Yarboi
Journal:  Am Psychol       Date:  2017 May-Jun

3.  Executive Functioning Mediates the Relationship Between Pain Coping and Quality of Life in Youth With Sickle Cell Disease.

Authors:  Natasha N Ludwig; Soumitri Sil; Meena K Khowaja; Lindsey L Cohen; Carlton Dampier
Journal:  J Pediatr Psychol       Date:  2018-11-01

Review 4.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

5.  Cognitive dysfunction associated with pain and quality of life in chronic rhinosinusitis.

Authors:  George S Tarasidis; Adam S DeConde; Jess C Mace; Shaelene Ashby; Timothy L Smith; Richard R Orlandi; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-22       Impact factor: 3.858

6.  Endoscopic sinus surgery improves cognitive dysfunction in patients with chronic rhinosinusitis.

Authors:  Jeremiah A Alt; Jess C Mace; Timothy L Smith; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2016-07-07       Impact factor: 3.858

7.  Association between high levels of inflammatory markers and cognitive outcomes at 4 years of age: The Rhea mother-child cohort study, Crete, Greece.

Authors:  Andriani Kyriklaki; Katerina Margetaki; Mariza Kampouri; Katerina Koutra; Panos Bitsios; Georgia Chalkiadaki; Eirini Dermitzaki; Maria Venihaki; Katerina Sarri; Despoina Anousaki; Manolis Kogevinas; Leda Chatzi
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

8.  Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease.

Authors:  Raven A Hardy; Noor Abi Rached; Jayre A Jones; David R Archer; Hyacinth I Hyacinth
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

Review 9.  Pretreatment Cancer-Related Cognitive Impairment-Mechanisms and Outlook.

Authors:  Brennan Olson; Daniel L. Marks
Journal:  Cancers (Basel)       Date:  2019-05-16       Impact factor: 6.639

10.  Laboratory Biomarkers, Cerebral Blood Flow Velocity, and Intellectual Function in Children with Sickle Cell Disease.

Authors:  Nataly Apollonsky; Norma B Lerner; Fengqing Zhang; Deepti Raybagkar; Jennifer Eng; Reem Tarazi
Journal:  Adv Hematol       Date:  2020-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.